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1. Introduction  
The association of cataract with glaucoma has become more frequent because of aging 
populations and the increased risk of cataract development in the patient with glaucoma. 
There is an increased risk of cataract in some forms of glaucoma, such as pseudoexfoliative 
glaucoma. In addition, glaucoma surgery increases the risk for the development of cataract 
(Hylton et al, 2003; AGIS investigators, 2001). With evolving techniques in both glaucoma 
and cataract surgery, the optimal management is ever changing in an effort to obtain a 
higher percentage of perfect results with fever complications and shorter recovery times. It 
has been widely reported that modern cataract surgery results in a long-term reduction in 
intraocular pressure (IOP); however, the magnitude and clinical significance of this change 
continues to be debated. On the other hand, due to the growing armamentarium of medical 
antiglaucomatous therapy during the past decade, most of these patients are presenting for 
cataract surgery. 
When a visually significant cataract is present and surgery is indicated, clinicians face 
several challenges.  Some anatomical features such as a shallow anterior chamber and a 
shorter axial length may complicate cataract surgery in eyes with angle closure glaucoma. 
Conversely, how to successfully control the IOP while managing the cataract may 
complicate the decision making process in eyes with primary open angle glaucoma (POAG) 
(Table 1). Glaucoma surgery may be associated with an increased risk of cataract 
progression (AGIS investigators, 2001). 
When glaucoma and cataract coexist, it is logical to think of a combined surgical procedure. 
This would help reduce surgical trauma and facilitate faster visual and functional recovery. 
Today’s rapidly advancing phacoemulsification techniques, including small incisions and 
foldable lenses implanted in the bag, as well as the improvements in glaucoma techniques, 
facilitate safer and more efficient combined surgery. Combined surgery may avoid the 
occurrence of postoperative IOP spikes following cataract surgery in eyes with advanced 
glaucoma (Shingleton et al, 2007). In addition, subsequent cataract surgery may compromise 
the success of an earlier trabeculectomy (Seah et al, 1996).  
Combined surgery for glaucoma and cataract is carried out in the presence of a cataract that 
disturbs function and either: 
 a glaucomatous condition that fails to respond to maximally tolerated medical therapy; 
 when there is appreciable visual field loss and optic disc damage independent of 
medical control; or 
 when transient IOP elevations might cause further optic nerve damage. 
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Trabeculectomy First; 
Cataract Extraction Later 
Cataract Extraction First; 
Trabeculectomy Later if Needed 
Combined Cataract and 
Glaucoma Surgery 
When large incision 
extracapsular cataract 
extraction is to be 
employed 
Well controlled, mild glaucoma 
with additional medical options 
available 
Advanced glaucoma 
 
 
When marked 
inflammation is present 
 
Ocular hypertension with 
additional medical options 
available 
Patients on maximally 
tolerated medical therapy 
or intolerant to 
medications 
When the risk of surgery is 
very high 
 
Patients with shallow anterior 
chamber 
 
Poor compliance to 
medications 
Low target intraocular 
pressure 
  Patients with coincident 
glaucoma and cataract 
requiring two or more 
medications 
  
Table 1. Options for Surgical Management of Coincident Cataract and Glaucoma 
New surgical methods with the potential to significantly reduce IOP, such as ab-interno 
trabeculotomy and trabecular meshwork bypass stents have recently gained popularity 
(Godfrey et al, 2009). Many surgeons currently believe the collector system has a better 
chance to survive if intervention is undertaken earlier, before the distal collector system 
collapses or before years of topical drug therapy cause outflow scarring. 
This chapter attempts to outline the current concepts in the management of cataract and 
glaucoma by evaluating the evidence in eyes with coincident cataract and glaucoma. 
2. Physiopathologic factors: The glaucomatous eye 
The glaucomatous eye for some of its characteristics is different from an eye without this 
pathologic condition. Factors related to glaucoma and other factors associated with its 
medical treatment are involved (Leske et al, 2002; Lichter et al, 2001; Collaborative Normal-
Tension Glaucoma Study Group, 1998a; Collaborative Normal-Tension Glaucoma Study 
Group, 1998b; Kass et al, 2002). The Glaucoma Treatment Study showed, after 5 years of 
follow-up, twice the incidence of patients needed cataract surgery when medication was the 
initial treatment as in patients who underwent glaucoma surgery as the initial treatment 
(Lichter et al, 2001). The explanation for this finding is unknown. The process seemed to be 
related to the dynamics of the aqueous and the effect of hypotensive drugs (Lee & Gedde, 
2004). 
The corneal endothelium is more affected in patients with glaucoma, which explains their 
higher rate of corneal edema after cataract surgery (Tanihara et al, 1995). Patients with 
glaucoma have a tendency to have a poor response to pharmacologic pupil dilation and 
need additional surgical dilation to achieve correct visualization and to avoid the existing 
hidden cortex masses. Preoperative nonsteroidal anti-inflammatory medications (NSAIDs) 
in combination with mydriatics may improve intraoperative dilation (Stewart et al, 1999). 
Ophthalmic viscosurgical devices (OVDs) can be used to increase pupil size. Pupil 
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stretching maneuvers, or the use of iris hooks or rings for pupil dilation are recommended. 
Lens zonules may also become partially fragmented and disintegrated, especially in patients 
with pseudoexfoliation syndrome (PES). In advanced cases with PES, the zonular 
suspension of the lens is weakened to such an extent that phacodonesis occur. The zonular 
fibers may be separated from their attachments to the lens or ciliary body, causing inferior 
dislocation of the lens. Loosening of the zonules may induce anterior lens dislocation with an 
attack of secondary angle-closure glaucoma (ACG), especially with the patient in the prone 
position (Ritch, 1994). There are a number of methods that can be used to manage zonular 
weakness. A capsular tension ring (CTR), a circular polymethyl methacrylate (PMMA) device, 
can be inserted into the capsular bag to manage mild cases of zonular instability, defined as 
less than or equal to four clock hours of dialysis (Jacob et al, 2003). In cases with more severe 
zonular weakness, a modified capsular tension ring (mCTR) can be sutured to the sclera 
(Cionni et al, 2003). Lastly, iris hooks may be used to gently retract the anterior capsule during 
surgery. As the newer acrylic one-piece intraocular lenses (IOLs) unfold slower when inserted, 
there may be less trauma to the capsule and zonules. This may be an advantage of these IOLs 
over three-piece lenses. In glaucomatous eyes, we also see greater alteration of the blood 
aqueous barrier, indicating a greater incidence of postoperative inflammation. 
3. Anesthesia 
Combined cataract and glaucoma procedures are generally performed under retrobulbar, 
peribulbar, or sub-Tenon’s anesthesia. Prior to the retrobulbar block, a combination of 
agents with short-acting sedative and amnesiac properties such as methohexitol 20 to 30 mg, 
midazolam HCl 1mg, or alfentanil 250µg may be given intravenously to reduce anxiety and 
pain. The retrobulbar block consists of 2% xylocaine without epinephrine. During the 
procedure only light sedation or none will be required. The patient’s systemic blood 
pressure must be controlled during the operation for many reasons, but primarily to reduce 
the risk of suprachoroidal hemorrhage.  
In patients with markedly elevated IOP, preoperative administration of intravenous 
mannitol will minimize the abrupt change in IOP following the incision. Osmotic agents are 
preferred over aqueous suppressants because they dehydrate the vitreous, thereby reducing 
vitreous volume. Aqueous suppressants on the other hand, retard aqueous production 
during the early postoperative period.  
4. Preoperative considerations 
The preoperative clinical examination is extremely important. Lid position and orbital 
anatomy should be evaluated to consider superior tunnel incision versus temporal corneal 
selection. The conjunctiva should be examined carefully. Topical steroids should be 
administered if the conjunctiva is inflamed. Topical miotics should be discontinued 3 days 
before the surgery. Pupillary response to pharmacologic dilation should be recorded. If 
dilation is poor, the patient should be informed of the likely need for pupil stretch or iris 
manipulation, which may result in anisocoria or pupillary distortion. Patients should be 
informed preoperatively about the intense character of the postoperative period, which will 
require frequent visits and prolonged visual recovery, beyond that expected for standard 
cataract surgery. Finally, the eye should be carefully examined for the presence of 
pseudoexfoliative material, which can be associated with a more aggressive postoperative 
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inflammatory response, weakened zonular fibers, and poor pharmacologic pupil dilation 
(Küchle et al, 1996). 
5. Intraocular lens choices for patients with glaucoma 
Patients with glaucoma have unique functional and structural characteristics that should be 
considered prior to combined surgery. Decreased contrast sensitivity may be improved with 
aspheric IOLs; however, if these lenses decenter, they may induce more aberration than 
spherical IOLs. Patients with glaucoma may have smaller pupils and zonular weakness that 
may be managed intraoperatively by meticulous surgical technique as well as adjunctive 
devices including CTRs. In the setting of zonular/capsular instability, there are a number of 
surgical options to place an IOL in good position including anterior chamber IOLs, iris-
sutured posterior chamber IOLs, sclera-sutured posterior chamber IOLs, and iris-claw IOLs, 
although some may exacerbate glaucoma and should be tailored to the individual patient. 
Posterior capsule opacification is a common postoperative problem and as it stands, surgical 
technique, IOL design and potentially IOL material may play a role in decreased incidence. 
Anterior chamber depth and axial length have been shown to change after glaucoma 
surgery and should be considered when calculating IOL power (Teichman & Ahmed., 2010). 
As both glaucoma and multifocal IOLs decrease contrast sensitivity, there has been much 
debate over whether multifocal IOL implantation into a glaucomatous eye is a reasonable 
practice (Ahmed & Teichman, 2008).  
6. Antimetabolites 
Adding pharmacologic adjuncts, such as 5-FU and mitomycin-C (MMC), to the combined 
procedure has become popular over the past decade. Both drugs act by inhibiting of 
proliferation of fibroblasts and probably also affect cell migration and extracellular matrix 
production. With rare exception, use of 5-FU with the procedure fails to demonstrate an 
advantage over the procedure when this antimetabolite is not used (Grady et al, 1993; Wong 
et al, 1994; Hurvitz, 1993). 
The results with MMC, however, show a reduction in IOP despite appreciable variability in 
the way in which MMC is applied. Published studies report different MMC concentrations, 
durations of exposure and techniques of physical application to the eye (Munden & Alward, 
1995; Lederer, 1996; Belyea et al, 1997; Carlson et al, 1997). 
These data raise the question about whether MMC is required for eyes undergoing primary 
surgery or whether MMC should be reserved for eyes with failed filtering blebs, eyes that 
have had previous surgery or eyes with difficult-to-manage secondary glaucomas. As MMC 
is used so variably and both the short- and long-term consequences of its use in combined 
surgery are not clearly known, a prospective, randomized, multicentred study merits 
consideration. 
A small piece can be cut from an edge of a triangular Weck-cel sponge using Mayo scissors 
and trimmed to 1 cm length. When wetted with an antimetabolite it expands to athin porous 
layer that can be easily tucked beneath the conjunctiva on both sides and posteriorly (Fig. 1). 
Smooth forceps are used to hold the conjunctival edge away from the sponge during the 
contact period. 
The choice of antimetabolite (if antimetabolite is to be used) and the duration of exposure 
are individualized, because there is no good evidence favoring any one technique either in 
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general or in specific patient situations. MMC is usually prepared as a solution containing 
0.2 to 0.4 mg/ml and placed on the episclera for 2 to 5 minutes. The antimetabolite 5-FU is 
used in a concentration of 50 mg/ml and left in place for 3 to 5 minutes. Some surgeons 
apply antimetabolite under the scleral flap also. Contraindications for use of 5-FU and MMC 
are shown in Table 2. 
 
Contraindications for Use of Antimetabolites 
Corneal and conjunctival disorders 
Lid function or position abnormalities 
Pregnant or nursing women 
Young children 
Patient contemplating pregnancy 
 
Fig. 1. Intraoperative application of 5-fluorouracil or mitomycin-C on sponge (From Bayer A 
ed. Glokom Cerrahisi, 1st edition. Ankara:MN Medikal & Nobel; with permission). 
7. Pupil management 
Glaucoma patients often present with pupils that do not dilate adequately for safe cataract 
surgery. Pupils may dilate poorly because: 
 there are posterior synechiae; 
 the iris sphincter is sclerotic; 
 an inflammatory membrane involves the iris and anterior lens capsule; 
 exfoliation syndrome is present with its consequent affect on the iris and lens capsule 
(Obstbaum, 2000). 
We prefer manipulating the pupil to achieve a diameter of at least 5 mm before beginning 
cataract curgery. This may result in permanently dilated and poorly reactive pupil during 
the postoperative period. The basic principle in dealing with a pupil that dilates poorly is to 
remove the physical adhesions between the iris and lens, such as posterior synechiae or 
membranes. Synechiae are separated from the anterior lens capsule using a spatula. 
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Membranes can be peeled using fine forceps. Care is taken not to cause a traumatic 
iridodialysis. Injecting a high-viscosity viscoelastic agent aids in assessing the extent of pupil 
dilation (Obstbaum, 2000). If the amount of pupil dilation is not adequate, the pupil is 
stretched either using two instruments, such as Kuglen hooks (Dinsmore, 1996). The 
surgeon introduces one Kuglen iris hook through the tunnel incision or a paracenthesis 
incision and a second Kuglen hook through a paracentehesis incision. The inferior and 
superior pupillary borders near the 6 and 12 o’clock meridian engaged with the hooks that 
are oriented in opposite directions (Fig. 2). The surgeon slowly stretches the pupil by 
pushing each hook toward the anterior chamber angle. The same manevuer is repeated at 
the 3 and 9 o’clock meridians. After this manevuer, the anterior chamber is filled with 
additional viscoelastic material to further enlarge the pupil. Alternatively, a single 
instrument, such as the Beehler pupil dilator can be used (Fine & Hoffman, 1997). If this 
streching does not result in adequate dilation, the surgeon may perform multiple 0.5 mm 
radial sphincterotomies using Vannas scissors (Fig. 3). Another option is to use iris 
retractors (Fig. 4) (Nichamin, 1993). Corneal stab incisions were made at the 1:00, 5:00, 7:00, 
and 11:00 positions to enlarge the pupil. The angle of the incisions adjacent to the 
phacoemulsification incision should be made parallel to the iris plane to minimize tenting of 
the peripheral iris toward the phacoemulsification hand piece entry site. 
 
Fig. 2. Pupilary sphincter is stretched in the vertical and horizontal meridians using Kuglen 
hook (From Bayer A ed. Glokom Cerrahisi, 1st edition. Ankara:MN Medikal & Nobel; with 
permission). 
8. Surgical techniques 
Many techniques have been proposed to solve the conflicting problem of a watertight 
cataract incision and a patent filtering glaucoma procedure. The current combined surgical 
techniques for cataract and glaucoma include: 
 phacoemulsification and trabeculectomy (phacotrabeculectomy); 
 extracapsular cataract extraction and trabeculectomy; 
 phacoemulsification and trabeculotomy; 
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 phacoemulsification and non-penetrating surgery; 
 phacoemulsification and endocyclophotocoagulation; 
 phacoemulsification and canaloplasty 
 
Fig. 3. Fine iris scissors such as Vannas make radial cuts 0.5 to 1 mm in iris sphincter at 
several locations (From Bayer A ed. Glokom Cerrahisi, 1st edition. Ankara:MN Medikal & 
Nobel; with permission). 
 
Fig. 4. İris hooks are placed through paracentesis incisions. Pupil is engaged, and hooks are 
pulled toward periphery (From Bayer A ed. Glokom Cerrahisi, 1st edition. Ankara:MN 
Medikal & Nobel; with permission). 
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8.1 Extracapsular cataract extraction and trabeculectomy 
Indications for combined extracapsular cataract extraction (ECCE) and trabeculectomy are 
similar to phacotrabeculectomy. Increased nucleus brunescence, reduced endothelial cell 
density, and Morgagni’s cataracts are factors that favor extracapsular technique rather than 
phacoemulsification. 
Fornix-based conjunctival peritomy is performed and conjunctiva is disinserted from the 
10:00 to 2:00 meridian. Cauterization is performed for conjunctiva and episcleral hemostasis. 
The superficial scleral flap (rectangular, triangular, or circular) is outlined approximately 
50% scleral thickness. It is usually placed in the center of the cataract incision, or at either 
end of it. A crescent knive is used to dissect the scleral flap. A groove is extended along the 
limbus on both sides at the base of the scleral flap. A stab incision is made to the anterior 
chamber adjacent to the anterior corner of the scleral flap, and the limbal groove. Anterior 
capsulotomy is performed using either envelope, or can opener technique. Continuous 
circular capsulorrhexis, slightly larger than that used for phacoemulsification can also be 
made. Multiple relaxing incisions may be made in the capsulotomy to facilitate nucleus 
removal. Cataract incision is extended to adequate width using corneoscleral scissors. After 
applying light pressure 2mm posteriorly to the incision with a forceps and additional force 
at the 6:00 meridian, the nucleus slides through the incision (Fig. 5). The lens cortex is 
removed in the usual fashion and posterior chamber IOL is implanted. The portion of the 
incision outside the scleral flap is closed with 10-0 nylon suture. The deep block of 
corneoscleral tissue is excised using either Vannas scissors or a Descemets’s punch and 
peripheral iridectomy is performed. The scleral flap is closed with 2 to 6 interrupted 10-0 
nylon sutures. The rate of aqueous outflow is checked by drying the flap area with a sponge 
as BSS is injected through the paracenthesis. Additional sutures are placed as needed to 
ensure a formed anterior chamber and moderate aqueous outflow. Finally, the conjunctiva 
is sutured with interrupted 10-0 nylon sutures in watertight manner. 
 
Fig. 5. Extracapsular cataract extraction combined with trabeculectomy. Nucleus removal 
using a forceps and hook (From Bayer A ed. Glokom Cerrahisi, 1st edition. Ankara:MN 
Medikal & Nobel; with permission). 
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8.2 Phacotrabeculectomy 
A preferred technique for phacotrabeculectomy is to mimic a standard trabeculectomy 
procedure. The globe is immobilized with a 4-0 nylon suture beneath the tendon of the 
superior rectus muscle. Alternatively, corneal traction suture (6-0 or 7-0 silk) can be used. 
The suture in this case is placed over a length of 3mm through the cornea at 12 o’clock 
parallel to the limbus at a limbal distance of approximately 0.5 mm. 
The conjunctiva is incised using scissors or a blade over a width sufficient to prepare a 
scleral flap. Either a fornix-based or limbus-based peritomy can be used. Fornix-based or 
limbus-based conjunctival flaps offer clinical advantages. Two retrospective studies in 
patients undergoing phacotrabeculectomy showed no difference in IOP control or visual 
acuity when either fornix-based or limbus-based conjunctival incisions were used (Tezel et 
al, 1997; Berestka & Brown, 1997). Some surgeons prefer the fornix-based flap is preferred 
bacause of beter visualization during cataract surgery, but this flap has more leakage and 
therefore patient follow-up is more complex, especially when antimetabolites have been 
used (Hoskins & Migliazzo 1994; Cohen et al, 1996). 
During 2-site phacotrabeculectomy, a limbus-based, 4X3mm rectangular, half-thickness 
scleral flap is dissected. The use of cautery should be limited so as to minimize 
postoperative inflammation. Some surgeons modify the shape and size of this scleral flap. 
Phacoemulsification is then performed through temporal corneal incision (Fig. 6), and 
intraocular lens is implanted into the capsular bag. Trabeculectomy opening (2X2 mm) is 
made using a Kelly Descemet’s punch (Bausch & Lomb Surgical) or alternatively using 
scissors. This is followed by peripheral iridectomy. Scleral flap was closed with 2 to 6 10-0 
nylon sutures. Black color is preferable because of the possible need for future suture lysis. 
The number of the sutures and their tightness should be adjusted during the operation. 
Injection of balanced salt solution into the anterior chamber permits intraoperative 
observation of pressure change and seepage of fluid at the edge of the scleral flap. The 
conjunctival-Tenon’s capsule flap is closed with two wing sutures for a fornix-based flap or 
by a continuous running suture for a limbus-based flap. With the 1-site approach a scleral 
tunnel incision is made superiorly and the surgeon’s preferred technique of 
phacoemulsification (Fig. 7) and IOL implantation is performed. Two radial incisions are made 
forward to the limbus and the tunnel incision is converted to a scleral flap. Trabeculectomy, 
iridectomy, scleral flap closure and conjunctiva closure is performed as mentioned above. Both 
1-site and 2-site approaches to phacotrabeculectomy have yielded satisfactory results. In two 
studies comparing the results of these two techniques, patients who had the 1-site procedure 
required significantly more medication to maintain IOP control than did the group who had 
the 2-site procedure (Wyse et al, 1998; El-Sayyad et al, 1999). 
Some surgeons have been eliminating the peripheral iridectomy step but there still remains 
the fear of incarceration and filtration failure. Kaplan-Messas et al randomized 36 patients to 
phacotrabeculectomy with and without iridectomy, 18 cases in each group. There were 11 
additional patients having trabeculectomy alone. IOP lowering success was equal between 
the groups. There were more hyphemas in the trabeculectomy alone without iridectomy 
group (Kaplan-Messas et al, 1999). Our preference is to perform iridectomy in all the cases 
except neovascular glaucoma. 
Newer technology has allowed cataract wounds to become smaller (Fig. 8). Whether an even 
less invasive cataract incision would translate into greater success and safety is unknown. 
We looked into the question of two-site phacotrabeculectomy compared to bimanual 
microincisional cataract surgery with trabeculectomy in 58 eyes and found very similar 
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success rates in regards of IOP. Complication rates were similar except for slightly more 
corneal edema in the two-site phacotrabeculectomy eyes (Bayer et al, 2009). 
 
Fig. 6. Two-site phacotrabeculectomy. Phacoemulsification of each quadrant after nuclear 
cracking (From Bayer A ed. Glokom Cerrahisi, 1st edition. Ankara:MN Medikal & Nobel; 
with permission). 
 
Fig. 7. One-site phacotrabecuelctomy. Phacoemulsification of each quadrant after nuclear 
cracking (From Bayer A ed. Glokom Cerrahisi, 1st edition. Ankara:MN Medikal & Nobel; 
with permission). 
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Fig. 8. Microincisional phacotrabeculectomy. Nucleus removal using an irrigating chopper 
and sleeveless phaco tip (From Bayer A ed. Glokom Cerrahisi, 1st edition. Ankara:MN 
Medikal & Nobel; with permission). 
Careful postoperative follow up after any filtration surgery is vital to the success of the 
operation. Postoperative care will determine the outcome of surgery in many cases. All 
glaucoma medications should be discontinued. Aggressive topical steroid use, for example 
every 2 hours while awake, is recommended during the postoperative week. Topical 
antibiotics are instilled for 1 week. Topical steroid administration is continued for 2 months 
postoperatively. Tapering of the steroid dose is based on the amount of inflammation in and 
around the bleb. The early postoperative period is critical. It is during this time that 
procedures often fail and complications are most common. If the IOP is high, focal pressure 
is applied adjacent to the filtration site with a cotton-tip applicator to augment filtration 
(Traverso et al, 1984). This technique is preferred, because it encourages outflow through the 
sclerostomy site and can dislodge fibrin or other debris that may be limiting outflow. If the 
IOP is very low, one would expect to see a huge bleb. Any discrepancy between bleb 
appearance and IOP should warrant examination of a bleb leak. Once adequate aqueous 
production is established, by a deep anterior chamber and stable or rising IOP, the surgeon 
may augment filtration by performing suture lysis (Fig. 9) or release. Finally, part of the 
routine postoperative regimen should include discussion to educate patients of the potential 
hazards of blebs such as late leaks or late bleb infections.  
 
Fig. 9. View of the flap suture under the Hoskins lens during suture lysis. 
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8.3 Phacotrabeculotomy 
Trabeculotomy has been reported to be effective in controlling IOP in eyes with POAG, 
pseudoexfoliation syndrome, and adult-onset glaucoma (Chihara et al, 1993; Tanihara et al, 
1993; Wada et al, 1994). 
Phacoemulsification and IOL implantation are performed as mentioned above, before the 
trabeculotomy ab externo. A clear corneal incision is made, and a corneoscleral incision after 
limbal peritomy is made in eyes to remove the cataract. After a continuous curvilinear 
capsulorrhexis, phacoemulsification and IOL implantation are performed. The 
trabeculotomy ab externo then is performed from a different site. The procedure begins with 
a limbal peritomy and radial conjunctival incision in the desired quadrant, and a fornix-
based conjunctival flap is prepared. Conjunctiva and Tenon’s tissue are retracted to expose 
the sclera. Apart from the site for cataract surgery, a 4 × 4-mm triangular area is marked, 
and the sclera is incised with a knife. A four-fifth thickness, limbal-based scleral flap is 
created. The outer wall of Schlemm’s canal, which is identified as a dark brown band 
between the sclera and the scleral spur, is radially incised with a sharp razor blade and 
removed using modified Vannas scissors. Care is taken not to disrupt the inner wall of 
Schlemm’s canal. Slow leakage of aqueous humor through the trabecular meshwork is 
confirmed under a surgical microscope. Semicircular trabeculotome probes (right and left) 
are inserted in both directions into Schlemm’s canal, and rotated in to disrupt the inner wall 
of the canal and the juxtacanalicular tissue of the trabecular meshwork. The scleral flap then 
is sutured watertight with three 10-0 nylon sutures, and the conjunctival wound is closed 
with interrupted 10-0 nylon sutures.  
Tanito et al. report that combined trabeculotomy and cataract surgery lowers IOP and has a 
low incidence of surgical complications (Tanito et al, 2001). A significant IOP reduction was 
observed in the trabeculotomy combined with phacoemulsification and IOL implantation 
(TPI group) and phacoemulsification and IOL implantation (PI) groups up to 3 years and up 
to 1 year and 6 months after surgery, respectively; the magnitude of the reduction was 
significantly larger in the TPI group.The success probabilities of TPI group for IOP control 
under 21, 17, and 15 mmHg were 95.8%, 58.7%, and 30.0%, respectively, 1 year after surgery. 
Tanito et al. suggestes that trabeculotomy can be a better option for the older patients. 
Lüke et al report that phacotrabeculotomy plus deep sclerectomy offered significant IOP 
reduction and a success rate that may be comparable with that of the current 
phacotrabeculectomy (Lüke et al, 2007). Intra- and postoperative complications specific to 
deep sclerectomy and trabeculotomy were seen in their series, although the overall rate of 
postoperative complications proved low. 
The Trabectome is a surgical device that was cleared by the US Food and Drug 
Administration in January 2004 for the treatment of adult and juvenile open-angle 
glaucoma. The concept is similar in principle to ab interno trabeculotomy, the key difference 
being that a microelectrocautery device is used to ablate a strip of the trabecular meshwork 
and inner wall of Schlemm’s canal, thus allowing direct access of aqueous to the collector 
channels. This theoretically bypasses the main site of resistance to aqueous outflow and 
reestablishes the natural drainage passageway out of the eye. Briefly, a 1.7-mm clear corneal 
incision is made temporally, through which the electrosurgical handpiece is inserted and 
advanced to the nasal angle under gonioscopic visualization. The tip of the device is 
inserted into Schlemm’s canal through the trabecular meshwork, and the cautery is then 
activated via a foot pedal. The handpiece is advanced while cautery is activated to ablate an 
arc of the meshwork, exposing the back wall of Schlemm’s canal, usually for 90° to 120°. A 
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modified Swan-Jacob goniolens (Ocular Instruments Inc, Bellevue, Washington) was 
developed for this procedure. The handpiece is then removed, and a single 10-0 suture is 
placed through the incision (Mosaed et al, 2009). This procedure has also been combined 
with microincisional phacoemulsification, and the IOP-lowering effect of the combined 
procedure has been previously reported to be 30% at 1 year in a study of 304 consecutive 
eyes (Francis et al, 2008; Minckler et al, 2008). 
The main complication reported in the use of the Trabectome is transient hyphema (79% to 
100%). There have been no reports of choroidal effusions, infections, or other permanent 
visual impairment. The potential advantages of this procedure are that it does not involve 
manipulation of the conjunctiva, the Tenon capsule, or sclera and therefore preserves the 
option for subsequent standard filtering surgery if necessary. There is also no risk of bleb-
related complications such as leaks, blebitis, endophthalmitis, dellen, and dysesthesia, as 
there is no bleb formation. Hypotony has been rare, most likely if an inadvertent 
cyclodialysis occurs. The IOP-lowering effect after several months appears to stabilize in the 
mid-teens through 5 years of follow-up (n = 10).9 After Trabectome, the majority of eyes 
require a reduced number of IOP-lowering medications. As a brief update on Trabectome, 
data now include IOP and medication outcomes on a total of 2,012 surgeries, including 1,228 
Trabectome-only and 687 combined Trabectome-phacoemulsification surgeries continuing 
to demonstrate that clinically significant IOP and adjuvant medication reliance decrease 
follow these surgeries. Updated survival analyses for these two groups are also 
encouraging, especially for the combined cases. 
8.4 Phacoemulsification and non-penetrating surgery 
For many years ophthalmic surgeons have tried to find a way of surgically lowering the IOP 
without creating a filtering bleb and the associated complications. These are bleb dysthesia, 
bleb leak, hypotony, blebitis, and bleb related endophthalmitis. One current trend in surgery 
for glaucoma is non-penetrating deep sclerectomy. Although we still do not have the same 
level of evidence for deep sclerectomy compared with trabeculectomy, some data support a 
similar efficacy of deep sclerectomy and trabeculectomy with a lower rate of complications. 
Because of these advantages, support for this technique has increased (Verges C et al, 2002; 
Gianoli F et al, 1999). By contrast, some reports show that the results of trabeculectomy are 
superior to those of deep sclerectomy (Chiselita D, 2001). 
Deep sclerectomy is aimed at reducing IOP by allowing the filtration of aqeous humor into 
the subconjunctival space through the trabeculo-descemetic membrane. The surgical 
technique varies; generally, after carrying out a fornix-based conjunctival peritomy, 5X5 mm 
superior scleral flap, approximately one-third of scleral thickness is dissected. At this stage, 
in all lor in selected cases only, sponge soaked with 5-FU or MMC is applied over the sclera. 
A limbus based deep scleral flap is then prepared leaving a thin layer of sclera over the 
choroid and the ciliary body. The dissection is carried anteriorly until Schlemm’s canal is 
deroofed and 1-2mm of Descemet’s membrane is exposed. At this stage, aqeous humor 
should be seen percolating through the trabeculo-descemetic membrane (Fig. 10). To 
increase percolation, some surgeons suggest removing the inner wall of Schlemm’s canal. 
Deep scleral flap is removed and implants are used to avoid postoperative scarring. The 
superficial flap is the sutured with two 10-0 nylon sutures. Conjunctiva is sutred with 
interrupted 10-0 nylon sutures.  
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Fig. 10. Title of figure, left justified 
Viscocanalostomy is similar to deep sclerectomy and Schlemm’s canal is cannulated using a 
specifically designed 165µm cannula and high molecular weight sodium hyaluronate is 
slowly injected into the both ostia (Fig. 11). The injection of viscoelastic substance allows 
progressive atraumatic dilatation of Schlemm’s canal. 
One advantage of deep sclerectomy is its results in combination with phacoemulsification. 
D’Eliseo et al. in a randomized prospective work, compared a group of 21 eyes treated with 
deep sclerectomy with another group of 21 eyes treated with combined phacoemulsification 
and deep sclerectomy (D'Eliseo D et al, 2003). The IOP values in the group of eyes treated 
with combined surgery were better (13.1 mm Hg) than in the group treated with deep 
sclerectomy alone alone (15.2 mm Hg). The authors achieved IOPs lower than 21 mm Hg 
without medication in 90% of eyes undergoing combined surgery as opposed to 62% of eyes 
undergoing deep sclerectomy alone. Moreover, the incidence of postoperative hypotony 
was also reduced in the combined surgery group (20% vs 32%, respectively). Gianoli et al. 
however, reported similar results when they compared phacotrabeculectomy and 
phacoemulsification plus deep sclerectomy with a collagen implant, observing the same rate 
of pressure reduction after 1 year of follow-up (Gionali F et al, 1999). 
Rebolleda et al. analyzed Descemet membrane perforations necessary to convert the deep 
sclerectomy to a trabeculectomy, reporting that in deep sclerectomy cases it was necessary 
to convert 8.9% after 7 to 28 month follow-up (Rebolleda et al, 2004). IOP values were 
similar to those obtained in cases not needing perforation. However, their reported 
complications, although not serious, were significant, with hyphema, choroidal detachment, 
and fibrinous uveitis. 
Viscocanalostomy obtained similar results to those of trabeculectomy during combined 
phacoemulsification. Park et al. observed IOP reduction and fewer glaucoma medications 
for IOP control (Park M et al, 2004). Whisart et al. also found similar results, with an IOP 
decrease of 37% in viscocanalostomy alone compared with 33% when combined with 
phacoemulsififcation (Park M et al ,2004).Uretmen et al. compared the safety and efficacy of 
viscocanalostomy and phacoviscocanalostomy in the management of medically 
uncontrolled open-angle glaucoma. In their study, 20 patients underwent  
phacoviscocanalostomy and 29 patients underwent viscocanalostomy alone. Significant 
reduction of IOP and medication occurred in both groups. The mean IOP reduction was 34% 
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in the eyes that underwent viscocanalostomy alone and 38% in the eyes that underwent  
phacoviscocanalostomy. The success rates of the two procedures were also comparable. In 
the combined surgery group, the best corrected visual acuity improved by two or more lines 
in 90% of the patients. Intraoperative complications did not occur in either group. The 
authors concluded that combining phacoemulsification with viscocanalostomy does not 
have a negative effect on the IOP control achieved by viscocanalostomy alone and does not 
increase the complication rate (Uretmen O et al, 2003). 
 
Fig. 11. Cannulation of Schlemm’s canal during viscocanalostomy (From Bayer A ed. 
Glokom Cerrahisi, 1st edition. Ankara:MN Medikal & Nobel; with permission). 
8.5 Phacoemulsification and endocyclophotocoagulation 
Endoscopic cyclophotocoagulation (ECP) is a new surgical approach which targets the 
ciliary processes to decrease aqueous humor production thus leading to lower IOP. The use 
of ECP is becoming more accepted and is no longer reserved for end-stage cases. Previously 
developed methods targeting the ciliary processes, such as cyclocryotherapy and diode 
cycloablation, are procedures done without direct visualization of treated tissue and have 
been reserved for cases with endstage glaucoma after which other medical and surgical 
modalities have failed to control IOP. The experience with these less precise modalities has 
led to a degree of apprehension and skepticism about the use of ECP. Still, the use of ECP 
has increased with more cases performed earlier in the course of treatment (Gayton et al., 
1999;  Chen et al., 1997; Kahook et al., 2007). 
ECP is carried out using a probe attached to a laser unit (Endo Optiks, Little Silver, NJ) 
which incorporates a diode laser. Pulsed continuous wave energy is emitted at 810 nm, 
using a 175 W variable xenon light source, a helium-neon laser aiming beam and video 
camera imaging. All elements are transmitted via fiberoptics within the probe. The 20 gauge 
probe provides a 70° field of view; the 18 gauge probe provides a 110° field. Power, 
duration, aiming beam intensity, and illumination are adjustable using controls on the 
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console. A foot pedal controls laser firing; the duration of treatment depends on how long 
the pedal is depressed. A retrobulbar or subtenons block with lidocaine and bupivicaine is 
preferred. After orientation of the probe image outside the eye, the probe is inserted 
intraocularly through a limbal incision. After visualization of the ciliary processes using the 
video monitor, treatment begins. 
The safety and efficacy of ECP has been demonstrated in treating various forms of glaucoma 
when performed alone or in combination with phacoemulsification (Uram, 1995). ECP 
procedure is performed following phacoemulsification and IOL implantation and before the 
viscoelastic removal. Combined phacoemulsification and ECP is commonly practiced with 
ECP performed, in most cases, through a single clear cornea incision allowing 
approximately 240 to 300 degrees of treatment (Fig. 12). The remaining 60 to 120 degrees of 
ciliary processes under the corneal incision are often left untreated with the potential to 
eventually result in inadequate IOP lowering or frank failure of the procedure. Some 
surgeons, prefer to perform ECP to 360 degrees through two corneal incisions. Transvitreal 
approach can also be used for ECP, especially in vitrctomised eyes (Haller JA, 1996). 
Complications of ECP include inflammation, hyphema, postoperative IOP spikes, choroidal 
detachment, choroidal hemorrhage, vitreous hemorrhage, hypotony, phtisis, and 
preogression to no light perception. ECP appears to be associated with a high rate of 
development of cataracts. 
 
Fig. 12. Position of the probe during endoscopic cyclophotocoagulation from a clear corneal 
incision (From Bayer A ed. Glokom Cerrahisi, 1st edition. Ankara:MN Medikal & Nobel; 
with permission). 
8.6 Phacocanaloplasty 
Canaloplasty is a new angle surgical procedure that involves conjunctival incision, 
fashioning a trabeculectomy-like scleral flap and a smaller deeper flap (similar to non-
penetrating surgery), which is excised to expose Schlemm’s canal. A flexible microcatheter 
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with fiber optic illumination at the distal tip is introduced into the canal and advanced for 
360° until visible opposite the entrance site. Viscoelastic is continually injected via the 
catheter lumen. A 10-0 Prolene suture is fastened to the distal catheter tip and then pulled 
back around the Schlemm’s canal while the catheter is withdrawn (Fig. 13). The suture is 
then tensioned by hand to distend the canal inward. The superficial flap is then closed 
watertight, followed by secure closure of the conjunctiva. An ultrasound device can be used 
to verify tensioning and stretching of the canal, if desired. 
Canaloplasty has also been successfully combined with phacoemulsification surgery (Lewis 
RA, 2011; Shingleton B, 2008). Lewis and colleagues have recently reported the 3 year results 
of combined phacoemulsification and canaloplasty. Eyes with combined cataract-
canaloplasty surgery had a mean IOP of 13.6 mm Hg on 0.3 ± 0.5 medications compared 
with a baseline IOP of 23.5 mm Hg on 1.5 ± 1.0 medications. Intraocular pressure and 
medication use results in all eyes were significantly decreased from baseline at every time 
point (Lewis RA, 2011). 
 
Fig. 13. Canaloplasty. Flexible microcatheter in Schlemm’s canal with 10-0 prolene suture 
fastened to the distal end. 
Benefits of this procedure over traditional glaucoma surgery include fewer complications, as 
it is not intended to create a bleb, therefore minimizing bleb-related complications. The most 
frequent early complication reported is hyphema. Late postoperative complications 
included cataract, transient IOP elevation, and partial suture extrusion through the 
trabecular meshwork. No bleb-related complications were reported so far.  
9. Conclusion 
Glaucoma surgery, as all the areas of ophthalmology, is changing rapidly. As the issue of 
cataract and glaucoma touches on two of the major and frequent problems, the choice of 
optimal care will certainly need to be re-evaluated. We now have new methods to benefit 
our patients and make a positive impact upon the quality of their lives. No uniform 
recommendations can be proposed for all cases. Clinicians have to consider a variety of 
factors before taking important surgical decisions. Greater safety can be provided by 
considering some of the newer glaucoma procedures. However, the ideal result has not yet 
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been realized. All of these new procedures have their own complications. We need to seek a 
better understanding of the variables in combined cataract and glaucoma surgery and to 
strengthen the evidence for adopting specific surgical techniques by designing multicentred, 
prospective, randomized trial. 
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